CENTRESTAGE Brings Together Global Brands to Showcase Inclusion and Diversity
14.9.2022 16:45:00 EEST | Business Wire | Press release
CENTRESTAGE 2022, one of Asia’s most anticipated annual fashion events, will be held from 9 to 11 September at the Hong Kong Convention and Exhibition Centre (HKCEC) Halls 1A-C. More than 240 fashion brands and designer labels from 15 countries and regions will take part in the three-day fashion presentation, promoting a wide variety of ready-to-wear apparel and accessories.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220904005055/en/
CENTRESTAGE Asia's Fashion Spotlight (Photo: Business Wire)
This year’s CENTRESTAGE revolves around the theme of “Inclusion and Diversity”, inviting visitors to express themselves boldly through fashion and at the same time, celebrating the differences between bodies, cultures and ideologies.
CENTRESTAGE will host more than 30 fashion events in these three days, including a series of brand shows and seminars. The opening gala show on 9 September at 7pm, CENTRESTAGE ELITES, will see the global launch of the latest collections from two designer brands – Derek Chan and Mite Chan’s renowned brand DEMO from Hong Kong, as well as acclaimed Japanese designer Hideaki Shikama’s Children of the discordance. Both Derek Chan and Hideaki Shikama were chosen as the 10 Asian Designer to Watch in 2020 by Fashion Asia Hong Kong. Watch the show live on CENTRESTAGE’s website.
CENTRESTAGE will again be open to public and trade visitors throughout the entire show period, providing an ideal platform for visitors to share the joys of fashion and shopping. A wide array of interactive experiences empowered by AR and VR technologies will be offered at the fairground to enrich visitors’ experience, including the brand new CENTREVERSE, a custom-built metaverse where visitors can interact and participate in fashion events using personalised avatars.
These are just among some of the highlights to look forward to at this year’s CENTRESTAGE. Register now for free admission or visit the event’s official website for more information.
CENTRESTAGE Elites opening gala show
Date: 9 September (Fri)
Time: 7:00-7:30pm
Live-stream: https://bit.ly/3wtFEVS
CENTRESTAGE 2022
Date: 9-11 September (Fri to Sun)
Venue: Hong Kong Convention and Exhibition Centre, Halls 1A-C
Register now for free: https://bit.ly/3CAAJqh
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220904005055/en/
Contact information
Media Enquiries
Please contact the HKTDC's Exhibitions Department:
Sum Luk
Tel: (852) 2240 4048
Email: cs.luk@hktdc.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Only AI Crypto Lead Prioritization Solution Built With Law Enforcement, for Law Enforcement: Elliptic Launches Pulse24.9.2026 16:15:00 EEST | Press release
Elliptic, the global leader in on-chain risk, today launched Pulse. Pulse puts crypto lead prioritization directly in the hands of every frontline law enforcement and government officer. Crypto now touches every part of law enforcement, from the patrol officer on the street to the detective assigned to investigate the case. Pulse gives each of them a quick, accurate financial summary and a starting point: whether that's a crypto address on a suspect's phone, in a scam ATM victim's receipt, uncovered during a vehicle or pocket search, or found at the scene of an overdose, an arrest, or a seizure. An officer can input anything that looks like a wallet address or transaction hash. Pulse identifies it, reasons over the result, and returns a summary in plain language, enough for the officer to decide on the spot whether the case needs escalation. If a case needs further investigation, one click sends the full analysis forward, not just the evidence. The criminal investigations division gets
SymphonyAI Introduces Symphony Risk Intelligence, an Agent-native Platform That Unlocks Always-on Compliance™ — the Catalyst for Transforming the Financial Crime Operating Model24.9.2026 16:04:00 EEST | Press release
SymphonyAI today introduced Symphony Risk Intelligence (SRI), an enterprise-grade, agent-native platform built to unlock Always-on Compliance™. This is a critical shift from periodic to continuous risk and compliance management, in which institutions continuously reassess risk and adapt controls as regulations, threats and business activity change, rather than waiting for the next scheduled review. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260924914614/en/ Current approaches have reached their structural limits. The FinCrime Frontier 2026–27 Report, released recently by SymphonyAI and AML Intelligence, finds just 4.7% of financial institutions continuously update their compliance monitoring and controls as risk changes, and 76.3% still review alerts manually or with only partial automation — barely changed year over year. Yet standing still isn't an option: the regulatory climate is at a major inflection point across ev
Just 4.7% of Financial Institutions Continuously Update Their Compliance Monitoring and Controls as Risk Changes, New Research Finds24.9.2026 16:04:00 EEST | Press release
SymphonyAI, a global leader in vertical AI product platforms, and AML Intelligence, the leading source of news and insight for the financial crime compliance community, today released the FinCrime Frontier 2026–27 Report, finding that most financial institutions still rely on periodic review cycles to manage financial crime risk, even as the threats and regulations they are meant to track continue to evolve dynamically. Based on the perspectives of more than 200 financial crime and compliance leaders, including senior leaders from major global financial institutions, the research finds that just 4.7% of financial institutions continuously update their compliance monitoring and controls as risk changes, while 56.8% have not adopted always-on compliance monitoring at all, are only exploring it, or remain at an early, pilot-stage level. The finding points to a structural gap: financial crime typologies, payment ecosystems and regulatory expectations are evolving continuously, while most c
Boomi Appoints Mike Hickman as Chief Financial Officer24.9.2026 16:00:00 EEST | Press release
Boomi, the data activation company for AI, today announced the appointment of Mike Hickman as Chief Financial Officer. Hickman will lead Boomi's global finance and accounting organization, spanning financial planning and analysis, accounting, treasury, tax, and financial reporting. He reports to Boomi Chairman and Chief Executive Officer Steve Lucas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260924761566/en/ Boomi Appoints Mike Hickman as Chief Financial Officer Hickman brings three decades of senior finance leadership in high-growth SaaS and technology companies, with experience across the full corporate lifecycle: scaling through IPO, executing a take-private, and integrating large acquisitions. He joins from Proofpoint, where he spent seven and a half years, most recently as Senior Vice President of Finance, helping guide the company through its $12.3 billion take-private and the $1.8 billion acquisition of Hornetsec
Altasciences Supports 4B Healthcare in Advancing Steroid Nasal Irrigation Rinse to Clinical Trials24.9.2026 15:40:00 EEST | Press release
Altasciences is proud to announce that recent formulation work supporting 4B Healthcare Inc. (“4B”) has helped advance its RhineX nasal irrigation rinse therapy into clinical investigation. Following several months of formulation development, R&D manufacturing, stability testing, and quality assurance support at Altasciences’ CDMO facility in Harleysville, PA, the Tennessee-based pharmaceutical company has received FDA clearance to proceed with clinical testing of RhineX under its IND. First subject dosing is planned for October 2026, approximately seven months after formulation development began. "The concept for RhineX grew out of a problem I have seen in my own ENT practice for years—the need for a better treatment option for allergic rhinitis when conventional medical therapy is not enough,” said Brannon Mangus, MD, Co-Founder and CEO of 4B. “We founded 4B Healthcare to take that physician insight and turn it into a pharmaceutical product that could meaningfully change how these pa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom